Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial.
Journal: Fertility and sterility
Published: August 04, 2021
Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis.
Journal: International journal of cancer
Published: January 15, 2018
Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Journal: Journal of assisted reproduction and genetics
Published: November 28, 2017
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Journal: Journal of assisted reproduction and genetics
Published: July 09, 2017
Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community.
Journal: Fertility and sterility
Published: March 27, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026